Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-28

FDA Approved: BLISOVI 24 FE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved BLISOVI 24 FE as an original application for a generic combination oral contraceptive containing norethindrone acetate and ethinyl estradiol, manuf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BLISOVI 24 FE (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)

Snippet

ORIG AP for BLISOVI 24 FE (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)